Neuland Laboratories Limited (NEULANDLAB.BO)
INR 11201.8
(2.31%)
INR 11201.8
(2.31%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.32 Billion INR | 16.0% |
| 2022 | 15.79 Billion INR | 14.19% |
| 2021 | 13.83 Billion INR | 4.43% |
| 2020 | 13.24 Billion INR | 7.62% |
| 2019 | 12.3 Billion INR | 8.9% |
| 2018 | 11.3 Billion INR | 5.5% |
| 2017 | 10.71 Billion INR | 20.98% |
| 2016 | 8.85 Billion INR | 8.42% |
| 2015 | 8.16 Billion INR | 59.68% |
| 2014 | 5.11 Billion INR | 5.8% |
| 2013 | 4.83 Billion INR | 13.76% |
| 2012 | 4.24 Billion INR | -0.18% |
| 2011 | 4.25 Billion INR | -0.51% |
| 2010 | 4.27 Billion INR | 7.49% |
| 2009 | 3.98 Billion INR | 6.58% |
| 2008 | 3.73 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 18.32 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 18.32 Billion INR | 16.0% |
| 2023 Q2 | 16.65 Billion INR | 0.0% |
| 2022 Q2 | 14.24 Billion INR | 0.0% |
| 2022 FY | 15.79 Billion INR | 14.19% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 15.79 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 13.89 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 13.83 Billion INR | 4.43% |
| 2021 Q4 | 13.83 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 13.13 Billion INR | 0.0% |
| 2020 FY | 13.24 Billion INR | 7.62% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 13.24 Billion INR | 0.0% |
| 2019 Q4 | 12.3 Billion INR | 0.0% |
| 2019 FY | 12.3 Billion INR | 8.9% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 11.81 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 11.3 Billion INR | 5.5% |
| 2018 Q4 | 11.3 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 10.71 Billion INR | 20.98% |
| 2016 Q3 | 5.84 Billion INR | 4.91% |
| 2016 Q1 | - INR | 0.0% |
| 2016 Q2 | 5.56 Billion INR | 0.0% |
| 2016 FY | 8.85 Billion INR | 8.42% |
| 2016 Q4 | 8.85 Billion INR | 51.62% |
| 2015 FY | 8.16 Billion INR | 59.68% |
| 2014 FY | 5.11 Billion INR | 5.8% |
| 2013 FY | 4.83 Billion INR | 13.76% |
| 2012 FY | 4.24 Billion INR | -0.18% |
| 2011 FY | 4.25 Billion INR | -0.51% |
| 2010 FY | 4.27 Billion INR | 7.49% |
| 2009 FY | 3.98 Billion INR | 6.58% |
| 2008 FY | 3.73 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 71.569% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 95.934% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 35.709% |
| Granules India Limited | 55.2 Billion INR | 66.807% |
| Indoco Remedies Limited | 21.44 Billion INR | 14.555% |
| Achyut Healthcare Limited | 309.52 Million INR | -5820.616% |
| Ajanta Pharma Limited | 46.38 Billion INR | 60.491% |
| Alkem Laboratories Limited | 155.74 Billion INR | 88.234% |
| Alpa Laboratories Limited | 1.82 Billion INR | -903.474% |
| Brooks Laboratories Limited | 904.45 Million INR | -1926.152% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -69.992% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -139.51% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -50.969% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 95.271% |
| Eris Lifesciences Limited | 70.48 Billion INR | 74.002% |
| FDC Limited | 24.68 Billion INR | 25.75% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 87.237% |
| Gufic Biosciences Limited | 10.92 Billion INR | -67.734% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -57.287% |
| Ipca Laboratories Limited | 111.01 Billion INR | 83.492% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -744.195% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -928.519% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1114.673% |
| Laurus Labs Limited | 83.87 Billion INR | 78.15% |
| Lupin Limited | 239.97 Billion INR | 92.363% |
| Mankind Pharma Limited | 119.63 Billion INR | 84.682% |
| Medicamen Biotech Limited | 2.94 Billion INR | -522.214% |
| Medico Remedies Limited | 961.95 Million INR | -1805.042% |
| Megasoft Limited | 3.65 Billion INR | -400.837% |
| NATCO Pharma Limited | 69.06 Billion INR | 73.465% |
| Piramal Pharma Limited | 153.11 Billion INR | 88.032% |
| RPG Life Sciences Limited | 5.12 Billion INR | -257.315% |
| Sigachi Industries Limited | 6.94 Billion INR | -163.998% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.856% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 18.701% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -352.86% |
| Unichem Laboratories Limited | 31.69 Billion INR | 42.179% |
| Wanbury Limited | 3.43 Billion INR | -433.507% |
| Windlas Biotech Limited | 6.26 Billion INR | -192.645% |
| ZIM Laboratories Limited | 4.46 Billion INR | -310.132% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 93.741% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -255.809% |
| Divi's Laboratories Limited | 154.7 Billion INR | 88.154% |
| Hester Biosciences Limited | 6.62 Billion INR | -176.677% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -130.697% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -399.511% |
| Bal Pharma Limited | 3.2 Billion INR | -471.98% |
| Strides Pharma Science Limited | 58.39 Billion INR | 68.619% |
| Venus Remedies Limited | 6.26 Billion INR | -192.354% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 29.028% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 16.362% |
| Shilpa Medicare Limited | 30.93 Billion INR | 40.755% |
| Aarti Drugs Limited | 24.32 Billion INR | 24.659% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 18.35% |
| Suven Life Sciences Limited | 2.84 Billion INR | -543.223% |
| Ind-Swift Limited | 6.54 Billion INR | -180.006% |
| Valiant Laboratories Limited | 3.42 Billion INR | -434.762% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 54.119% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | 22.051% |
| Themis Medicare Limited | 5.66 Billion INR | -223.536% |
| Hikal Limited | 24.87 Billion INR | 26.319% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 87.832% |
| Sequent Scientific Limited | 15.4 Billion INR | -18.968% |
| Novartis India Limited | 9.24 Billion INR | -98.13% |
| Wockhardt Limited | 76.49 Billion INR | 76.042% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 84.132% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -3792.217% |
| Morepen Laboratories Limited | 12.93 Billion INR | -41.707% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -663.371% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -449.618% |